Welcome to LookChem.com Sign In|Join Free
  • or
2-Methyl-4-hydroxybutanoic acid sodium salt is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

107975-82-6

Post Buying Request

107975-82-6 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

107975-82-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 107975-82-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,7,9,7 and 5 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 107975-82:
(8*1)+(7*0)+(6*7)+(5*9)+(4*7)+(3*5)+(2*8)+(1*2)=156
156 % 10 = 6
So 107975-82-6 is a valid CAS Registry Number.

107975-82-6Downstream Products

107975-82-6Relevant academic research and scientific papers

NOVEL PHARMACEUTICAL COMPRISING HETEROAROMATIC AMIDE DERIVATIVE OR SALT THEREOF

-

Paragraph 1988-1989, (2021/09/17)

PROBLEM TO BE SOLVED: To provide a compound useful for treating or preventing disease associated with voltage-dependent sodium channel (Nav1.7) such as disease involving a pain, disease involving an itch, autonomic nerve-associated disease, or a pharmaceutical composition thereof. SOLUTION: The present disclosure provides a compound illustrated by the following formula, and a pharmaceutical composition containing the same. SELECTED DRAWING: None COPYRIGHT: (C)2021,JPOandINPIT

Macrocyclic lactone HMG-CoA reductase inhibitors

-

, (2008/06/13)

Novel 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors which are useful as antihypercholesterolemic agents and are represented by the following general structural formula (I): STR1 are disclosed. Also disclosed are pharmaceutical compositions and methods of use of the compounds of formula (I).

Novel HMG-CoA reductase inhibitors

-

, (2008/06/13)

Novel 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors which are useful as antihypercholesterolemic agents and are represented by the following general structural formulae (I) or (II): STR1 wherein: n is 1 to 5; R is hydrogen or STR2 R1 is hydrogen or methyl; R2 is hydrogen or methyl; and R3 is hydrogen, C1-5 alkyl or C1-5 alkyl substituted with a member of the group consisting of phenyl, dimethylamino, or acetylamino; and the dotted lines at a, b and c represent optional double bonds and pharmaceutically acceptable salts of the compounds (II) in which R3 is hydrogen are disclosed.

KINETIC RESOLUTION OF LACTONES BY ENANTIOSELECTIVE PROTONATION OF THE CORRESPONDING CARBOXYLATE WITH A CHIRAL ACID

Fuji, Kaoru,Node, Manabu,Murata, Makoto,Terada, Shunji,Hashimoto, Keiji

, p. 5381 - 5382 (2007/10/02)

Racemic lactones were optically activated through the hydrolysis with sodium hydroxide followed by the partial neutralisation with (1S)-(+)-10-camphorsulfonic acid in ethanol to afford R- or S-isomer with 99 - 38percent ee.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 107975-82-6